Takeda To Create Wholly Owned Sales Units In Four Countries
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical says it plans to create sales and marketing units in four countries by the end of October. The firm said Belgium, Mexico, Sweden and Turkey are to be the new locations for Takeda wholly owned subsidiaries. The units are to sell the range of Takeda products, including its Actos (pioglitazone) drug for treating diabetes. (Click here for more - a subscription may be required
|
Takeda Pharmaceutical says it plans to create sales and marketing units in four countries by the end of October. The firm said Belgium, Mexico, Sweden and Turkey are to be the new locations for Takeda wholly owned subsidiaries. The units are to sell the range of Takeda products, including its Actos (pioglitazone) drug for treating diabetes. (Click here for more - a subscription may be required) "Takeda: To Establish Four Overseas Sales, Marketing Units" - Wall Street Journal (Dow Jones) (10/1/09) |